Online survey to assess health risk factors and drug interactions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify and evaluate health-associated risk factors, particularly focusing on clinical-pharmacological aspects such as polypharmacy and drug interactions. Utilizing telecommunication technology, participants will complete a continuous online survey designed to gather data on self-medication practices, biologically active food supplement intake, and other demographic and behavioral characteristics. The survey is conducted through a specially designed website, with invitations sent via SMS to ensure broad participation across various regions. The findings may contribute to developing a decision support system to manage previously unrecognized risk factors, particularly in the context of the COVID-19 pandemic.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age of 18 years and older
* signing the informed concent form online
* completion of the entire questionnaire

Exclusion Criteria:

* age under 18 years
* refuse to sign the informed concent form

Where it's running

• Tomsk National Research Medical Center, Russian Academy of Sciences
  Tomsk, Russia Recruiting

Study contacts

• Principal investigator: Nina D Anfinogenova, PhD — Tomsk NRMC
• Study coordinator: Nina D Anfinogenova, PhD
• Email: anfiyj@gmail.com
• Phone: +73822554111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) in Adults

  This study tests and compares the immune responses and tolerability of the latest COVID-19 vaccines from Novavax and Pfizer/BioNTech in adults at risk for severe COVID-19.

  Recruiting Phase 4 Henry M. Jackson Foundation for the Advancement of Military Medicine · Bethesda, Maryland · NCT07287137

• Optimizing LDL cholesterol levels using inclisiran for patients with drug interactions

  This study is testing if inclisiran can help lower LDL cholesterol in patients with multiple health issues who can't take statins due to other medications.

  Recruiting Phase 4 University of California, San Diego · La Jolla, California · NCT06865885

• Omicron-based COVID-19 vaccine with Matrix-M given as a single dose in older adults and high-risk individuals

  A single-dose Omicron-subvariant vaccine with Matrix-M is tested to see if it is safe and can induce an immune response in adults 65+ and in younger adults with conditions that raise the risk of severe COVID-19, who were previously vaccinated.

  Recruiting at 20 sites Phase 4 Sanofi · Fair Oaks, California and 19 other locations · NCT07861542

• Secutrelvir for nonhospitalized COVID-19 in teens and adults

  This study tests whether secutrelvir can help nonhospitalized people with COVID-19 see faster symptom relief compared with a placebo.

  Recruiting Phase 3 Shionogi Inc. · Multiple Locations · NCT07746544

• Virological Monitoring of Seasonal Respiratory Infections in France

  This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.

  Recruiting Institut National de la Santé Et de la Recherche Médicale, France · Paris · NCT07599449

• COVID-19 Registry at San Matteo (SMACORE) - patient-matching observational registry

  This registry tests how COVID-19 patients are being treated and progress across San Matteo in Pavia to understand patterns and outcomes.

  Recruiting Fondazione IRCCS Policlinico San Matteo di Pavia · Pavia · NCT07597876

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.